It is the first study in the VA health system to examine whether doctors gaining knowledge of their patients’ genomic composition can help shape more precise treatment plans for depression. Dr. Lee, a VA medical examiner, signed up to be part of a first-of-its-kind experiment that is playing out in 21 VA health centers around the country. For the first time since he began practicing medicine in 1992, Lee is asking a small number of his patients to take a cheek swab for a genetic test analyzing their ability to metabolize commonly prescribed antidepressants. Lee uses the information to help decide which and how much of an antidepressant to prescribe. Read more here: http://www.sfchronicle.com/business/article/In-a-first-Veterans-Affairs-centers-use-genetic-12761544.php Article by Catherine Ho.
Mr. Finkelstein is the Managing Partner of Finkelstein & Partners, LLP. He has become a noted consumer activist through his representation of injured individuals against corporate wrongdoers and irresponsible parties.
An accomplished litigator, Mr. Finkelstein has represented Plaintiffs in wrongful death and catastrophic personal injury cases. He has successfully handled dozens of multi-million dollar cases.